From BIO Boston: Steve Butts, CEO of Arrivo BioVentures
In this episode, I sit down with Steve Butts — a five-time biotech founder and the CEO of Arrivo BioVentures.
Steve has built and exited multiple companies, and now he's applying everything he’s learned to build Arrivo with precision: lean, capital-efficient, and structured for smart growth.
We talk about:
— How to build programs that big pharma wants
— Why Arrivo structures its assets in separate subsidiaries
— Navigating the current market as a small, focused team
— And the mindset it takes to keep building in tough conditions
Steve’s approach is clear, disciplined, and proven - this is biotech company-building done right.
This episode is part of a series of in-person interviews from BIO Boston with some of the sharpest leaders in the industry.
More to come.